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Objective: Doppler ultrasound of extracranial internal carotid artery (ICA) and
vertebral artery (VA) were performed and total cerebral blood flow volume (tCBFV)
was evaluated in chronic obstructive pulmonary disease (COPD) patients. CBFV
changes due to blood gas changes were also evaluated.
Methods: Bilateral ICA and VA have been examined with 7.5MHz linear array
transducer in COPD patients. Angle-corrected time averaged flow velocity and cross-
sectional areas of vessels have been measured. Flow volumes and tCBFV have been
calculated. Flow velocities and waveform parameters have been measured.
Results: tCBFV, anterior–posterior CBFVs, left–right ICA flow volumes, bilateral ICA
and VA cross-sectional areas and left ICA peak-systolic velocity were significantly
higher in COPD patients than control group. Among COPD patients tCBFVs were
highest in hypoxemic–hypercapnic ones, and lowest in normocapnic ones. Bilateral
VA flow volumes, bilateral ICA (except left ICA Vps) and VA flow velocities and
waveform parameters were not different in COPD patients compared with control
group. When compared among the subgroups of COPD patients, there were no
significant differences for all parameters.
Conclusion: tCBFVs were found to be significantly higher in COPD patients. This
increment which is probably due to balancing the oxygen deficit is low with
hypoxemia and high with hypercapnia and hypoxemia. Particularly, bilateral ICA and
VA cross-sectional area changes and increased left ICA Vps were considered as the
main reason for increased tCBFV in COPD patients.
& 2006 Elsevier Ltd. All rights reserved.Elsevier Ltd. All rights reserved.
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Studies with healthy humans and animals reported
that cerebral blood flow (CBF) increases due to
cerebral vasodilatation during hypercapnia and
decreases due to cerebral vasoconstriction during
hypocapnia.1,2 In case of hypoxemia, CBF either
minimally or markedly increases due to cerebral
arteriolar dilatation.3,4 Changes in CBF during
hypercapnia, hypocapnia and hypoxemia in chronic
obstructive pulmonary disease (COPD) patients are
not clear. Some studies reported elevated levels of
CBF,5,6 whereas other studies reported decreased
levels.7 In other words, some studies showed
decreased ventilation although it was expected to
increase due to chronic hypercapnia,8,9 whereas
other studies showed decreased arterial carbon
dioxide tension (PCO2) and CBF levels with mechan-
ical ventilation with oxygen (O2) enrichment.
5,6
One of the primary aims of cerebrovascular
Doppler ultrasound is the analysis and character-
ization of cerebral hemodynamics under physiolo-
gic and pathologic circumstances. Although
invasive single positron emission computed tomo-
graphy (SPECT) and positron emission tomography
(PET) studies are the gold standards for the
evaluation of CBF, Doppler ultrasound enables
simple, easy, prevalent and noninvasive estimation
of CBF.10,11
CBF and cerebral blood volume (CBV) measure-
ments using PET in normal subjects during hyper-
capnia and hypocapnia have been reported
previously in the literature.12 Besides, CBV mea-
surement with near-infrared spectroscopy (NIRS)
method,7,13 CBF velocity measurement with tran-
scranial Doppler ultrasound,5 and CBF measure-
ment with Kety–Schmidt technique6 were already
defined in COPD patients. However, to the best of
our knowledge, extracranial carotid Doppler esti-
mation of cerebral blood flow volume (CBFV) in
COPD patients has not been reported before.
We aimed to evaluate CBFV and hemodynamic
changes that occur in extracranial carotid and
vertebral arterial systems with Doppler ultrasound
in COPD patients. We also aimed to evaluate the
changes in cerebral circulation during normocap-
nia, chronic hypoxia and chronic hypercapnia–
hypoxia in these patients.Materials and methods
This study is performed in an university hospital
setting. From the 29 patients in the study group,
two patients with cardiac deficiency, one patientswith untreated arterial hypertension, two patients
with severe dolicoectasic changes in bilateral
internal carotid artery (ICA) and vertebral artery
(VA) and four patients with atherosclerotic plaques
and stenosis were excluded from the study. Twenty
COPD patients (mean age, 66.879.6 years) and 22
healthy subjects (mean age, 66.179.9 years) were
accepted to the study. All the patients and the
control subjects were living in the same region. All
the patients were selected from outpatient clinic.
Hypertensive patients were under treatment with
antihypertensive drugs. Arterial blood pressures
were within normal limits in all patients and control
subjects before the measurements were per-
formed. Eleven patients with COPD were current
smokers. The patients with COPD were divided
into three groups; four patients with normocapnic
COPD (PaCO246.0 kPa), 10 patients with hy-
poxemic COPD (PaO2o8 kPa) and six patients
with hypoxemic–hypercapnic COPD (PaO2o8 kPa,
PaCO246.0 kPa).
8
Control subjects were selected randomly from
the volunteers who admitted to the hospital for
check-up. Those experiencing significant hemody-
namic disturbances and had a history or signs of
pulmonary and cerebrovascular disease, or cardiac
insufficiency were excluded. All of the subjects
were evaluated by the same pulmonologist and
their physical examinations were in normal limits.
Smoking, alcoholism and alcohol or caffeine use in
the last 2 days were other exclusion criteria in the
study group. Informed written consent was ob-
tained before the examination.
Doppler ultrasounds were performed in a room
with a comfortable temperature after an accom-
modation period for at least 15min rest in supine
position. It was performed with a 7.5-MHz linear
array transducer of a color-coded ultrasound
system (Nemio 20; Toshiba, Japan). The volunteers’
head slightly elevated and turned to the opposite
side by 25–401 for ICA measurements and by 101 for
VA measurements. Site of measurement of the ICA
was 1.5 cm distal to the carotid bifurcation and the
VA was examined between the transverse processes
of the vertebrae C4 and C5. All the ultrasound
examinations have been performed by the same
radiologist. The exam was blinded to whether the
subject was a COPD patient or a volunteer.
Measurement of angle-corrected flow velocities
was done with the sample volume expanded over
the entire vessel diameter. Visual control of the
maximal luminal width and acoustic control of an
optimum time frequency Doppler signal made
certain that the sample volume passed through
the center of the vessel. We aimed to keep the
angle of insonation as low as possible, in most cases
ARTICLE IN PRESS
R. Albayrak et al.1828it was about 601. Angle-corrected time averaged
flow velocity (TAV) was determined as the integral
of the mean flow velocities of all moving particles
passing the sample volume over three–five com-
plete cardiac cycles. In this way, pulsatile parabolic
flow is mathematically transformed into a contin-
uous plug flow. The measurements of TAV, peak-
systolic velocity (Vps) and end-diastolic velocity
(Ved) were taken in bilateral ICA and VA. In
addition, resistance index (RI) was calculated
according to RI ¼ (Vps—Ved)/Vps and pulsatility
index (PI) was calculated as: PI ¼ (Vps—Ved)/time
averaged maximum velocity. The intravascular flow
volume (FV) of each artery was calculated by the
formula: FV ¼ TAV cross-sectional area (A). The
cross-sectional area of the circular vessel was
calculated from the inner vessel diameter (d) using
the formula: A ¼ ðd=2Þ2  ½p.
We detected ICA and VA intravascular flow
volumes. The CBF was calculated as the sum of
flow volumes in the ICA and VA of both sides. All
measurements were documented by video printer.
Statistical analysis was performed using the SPSS
software for Windows (SPSS 10, Chicago, IL, USA).
The power of our study was found 495% when the
COPD group and its subgroups separately compared
with the control group with regard to total cerebral
blood flow volume (tCBFV). Mann–Whitney U and
Kruskal–Wallis tests were used. All parametric
results were expressed as mean7SD for each group.
Local statistical significance was assumed as
Po0.05 for all parameters.Table 1 Demographic features, pulmonary function test
Normocapnic
COPD (n ¼ 4)
Hipoxic COPD
(n ¼ 10)
Hipo
COP
Mean7SD Mean7SD Mea
Age 70.779.6 63.0710.4 64.2
BMI 24.673.6 29.275.9 24.7
FVC 2.171.1 1.870.4 1.8
FEV1 1.471.0 0.970.3 1.0
FEF25–75 1.271.1 0.971.1 0.6
FVC% 56.4720.5 47.576.0 52.0
FEV1% 48.4724.4 31.8715.6 37.3
FEV1/FVC 66.4715.8 42.074.3 53.7
FEF25–75% 36.0729.7 28.5733.7 20.5
pH 7.4473.50 7.4575.30 7.40
PCO2 (kPa) 5.270.6 5.370.6 7.7
PO2 (kPa) 9.770.9 6.570.9 6.0
HCO3 (mmol/L) 25.672.0 27.772.1 33.2
SatO2 94.771.6 83.977.3 73.2
BMI, body-mass index; FVC, forced vital capacity; FEV1, forced exp
PCO2, arterial carbon dioxide tension; PO2, arterial oxygene tensResults
There was no significant difference between age
(P ¼ 0:950) and genders (P ¼ 0:921) of COPD and
control groups. Demographic features, pulmonary
function test results and arterial blood gases were
shown in Table 1. Pulmonary function tests re-
vealed that absolute and percentage predicted
values of forced vital capacity (FVC), forced
expiratory volume in 1 s (FEV1), forced expiratory
flow 25–75 (FEF25–75) and the value of FEV1/FVC
were significantly higher in control group than
COPD patients. tCBFV were significantly higher in
COPD patients than control group (Po0.0001). In
COPD patients, anterior CBFV (aCBFV) which is the
sum of bilateral ICA flow volumes (Po0.0001),
posterior CBFV (pCBFV) which is the sum of
bilateral VA flow volumes (P ¼ 0:005), left ICA flow
volume (Po0.0001) and right ICA flow volume
(P ¼ 0:001) values were significantly higher com-
pared to control group (Table 2). Although left and
right VA flow volumes were higher in COPD patients
than control group, there were no statistically
significant differences between them (P ¼ 0:052,
0.059, respectively). However, net VA flow volume
[(left VA flow volume+right VA flow volume)/2] was
significantly higher in COPD patients than control
group (P ¼ 0:005). Cross-sectional areas of bilateral
ICA and VA were significantly higher in COPD
patients than in control group (Po0.05) (Table 3).
Left ICA Vps was significantly higher in COPD
patients than in control group (P ¼ 0:028)results and arterial blood gases of COPD patients.
xic–hypercapnic
D (n ¼ 6)
Control
(n ¼ 22)
P values
n7SD Mean7SD
78.1 66.179.9 0.517
72.5 25.272.8 0.556
70.6 4.070.5 0.000
70.5 3.870.4 0.000
70.4 5.171.0 0.000
716.1 89.579.8 0.000
720.3 101.1710.6 0.000
714.9 94.774.9 0.000
715.9 118.1722.6 0.000
75.30 — 0.213
71.3 — 0.005
71.5 — 0.007
76.9 — 0.117
712.7 — 0.004
iratory volume in 1 s; FEF25–75, second forced expiratory flow;
ion.
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Table 2 tCBFV, anterior–posterior CBFV and flow volumes in internal carotid and vertebral arteries of COPD
patients and controls.
Volume (mL/min)
COPD Controls P values
Mean7SD Median Range Mean7SD Median Range
tCBFV 8327169 808.0 632.0 598756 586.0 181.0 o0.0001
aCBFV 6287150 614.0 626.0 441787 438.5 436.0 o0.0001
pCBFV 204749 192.5 183 157775 156.5 342.0 0.005
LICA 3207101 310.0 385.0 217760 227.5 256 o0.0001
RICA 308785 307.0 368.0 224749 218.5 251.0 0.001
LVA 108732 111.5 135 88761 68.0 228.0 0.052
RVA 96756 84.0 242.0 68747 54.0 169.0 0.059
tCBFV, total cerebral blood flow volume; aCBFV, anterior cerebral blood flow volume; pCBFV, posterior cerebral blood flow
volume; LICA, left internal carotid artery; RICA, right internal carotid artery; LVA; left vertebral artery; RVA, right vertebral
artery. All parameters were expressed as mean7SD.
Table 3 Cross-sectional area in internal carotid and vertebral arteries of COPD patients and controls and P
values.
Cross-sectional area (mm2)
COPD Controls P values
Mean7SD Median Range Mean7SD Median Range
LICA 16.374.1 15.0 13.0 13.575.1 12.5 22.0 0.023
RICA 17.473.7 17.5 13.0 13.373.9 14.0 16.0 0.002
LVA 7.872.5 8.0 11.0 5.872.2 6.0 8.0 0.015
RVA 8.172.7 8.0 10.0 5.771.8 5.5 8.0 0.001
LICA, left internal carotid artery; RICA, right internal carotid artery; LVA, left vertebral artery; RVA, right vertebral artery. All
parameters were expressed as mean7SD.
Table 4 Flow velocities in internal carotid and vertebral arteries of COPD patients and controls.
Flow velocity (cm/s)
COPD Controls P values
Mean7SD Median Range Mean7SD Median Range
LICA Vps 62.1718.9 65.4 69.2 51.8714.9 53.9 65.5 0.028
LICA Ved 18.976.7 20.8 18.6 18.176.6 19.9 27.1 0.623
RICA Vps 54.5718.3 51.3 75.8 54.4714.4 51.5 51.6 0.880
RICA Ved 16.975.4 16.1 23.6 18.175.2 17.8 20.2 0.345
LVA Vps 40.9712.5 39.5 49.8 37.7712.1 39.4 40.2 0.457
LVA Ved 11.774.8 11.3 21.4 11.375.6 9.3 21.3 0.435
RVA Vps 38.4713.9 38.6 53.8 36.6711.3 33.9 49.2 0.496
RVA Ved 9.974.3 11.6 15.3 10.374.5 9.5 18.1 0.910
LICAVps, left internal carotid artery peak-systolic velocity; LICAVed, left internal carotid artery end-diastolic velocity; RICAVps,
right internal carotid artery peak-systolic velocity; RICA Ved, right internal carotid artery end-diastolic velocity; LVA Vps, left
vertebral artery peak-systolic velocity; LVAVed, left vertebral artery end-diastolic velocity; RVAVps, right vertebral artery peak-
systolic velocity; RVA Ved, right vertebral artery end-diastolic velocity. All parameters were expressed as mean7SD.
Evaluation of CBFV in COPD patients 1829(Table 4). No statistically significant differences
were found in (except left ICA Vps) both ICA and VA
Vps, Ved, RI and PI values (P40.05).The patients with COPD were divided into three
groups according to blood gases; normocapnic,
hypoxemic and hypoxemic–hypercapnic groups.
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Table 5 tCBFV, anterior–posterior CBFV and flow volumes in internal carotid and vertebral arteries of subgroup
COPD patients and controls.
Volume (mL/min)
Normocapnic COPD Hipoxic COPD Hipoxic–hypercapnic COPD Controls P values
tCBFV 774722 8147184 9017195 598756 o0.0001
aCBFV 570750 6137157 6917179 441787 o0.0001
pCBFV 203734 200750 210761 157775 0.048
LICA 284723 3227125 340796 217760 0.003
RICA 286745 291781 3507108 224749 0.005
LVA 113743 110736 100718 88761 0.232
RVA 89766 90740 109778 68747 0.274
tCBFV, total cerebral blood flow volume; aCBFV, anterior cerebral blood flow volume; pCBFV, posterior cerebral blood flow
volume; LICA, left internal carotid artery; RICA, right internal carotid artery; LVA, left vertebral artery; RVA, right vertebral
artery. All parameters were expressed as mean7SD.
Table 6 Cross-sectional area in internal carotid and vertebral arteries of subgroup COPD patients and controls.
Cross-sectional area (mm2)
Normocapnic COPD Hipoxic COPD Hipoxic–hypercapnic COPD Controls P values
LICA 15.074.7 17.173.6 15.674.8 13.575.1 0.089
RICA 16.774.8 17.673.9 17.572.9 13.373.9 0.002
LVA 8.072.1 8.573.0 6.671.5 5.872.2 0.059
RVA 8.570.5 8.572.4 7.373.8 5.771.8 0.005
LICA, left internal carotid artery; RICA, right internal carotid artery; LVA, left vertebral artery; RVA, right vertebral artery. All
parameters were expressed as mean7SD.
R. Albayrak et al.1830Among COPD patients tCBFV, aCBFV, pCBFV, left
and right ICA flow volumes were highest in
hypoxemic–hypercapnic ones and lowest in normo-
capnic ones (Table 5). Right ICA (P ¼ 0:02) and VA
(P ¼ 0:005) cross-sectional areas were significantly
higher in normocapnic, hypoxemic and hypoxemi-
c–hypercapnic COPD patients than in control group
(Table 6). Left and right VA flow volumes, left ICA
and VA cross-sectional areas, bilateral ICA and VA
flow velocities and waveform parameters were
statistically insignificant among these three groups
(P40.05).
There were no significant correlations between
CBFV and values of PaO2 and PaCO2. We also did not
find significant correlation between CBFV and age,
blood pressure, medication.Discussion
CBF increases due to cerebral arteriolar vasodilata-
tion in hypoxemia, a relation defined in many
human and animal studies.14,15 Levasseur et al.16
observed vasodilatation in pial arteries in rabbitsexposed to long-term hypoxemia. There is a
general consideration about a linear relationship
between decrease in oxygen and increase in CBF.17
However, in some studies, a gradual increase
whereas in other studies a progressive increase in
CBF due to hypoxemia was reported.18–20 Hasegawa
et al.15 performed continuous CBF measurements
with transcranial Doppler ultrasound during hypox-
emia and found no differences with mild hypoxemia
(18% O2), whereas an increase in CBF with severe
hypoxemia (10% O2). The increment in CBF due to
hypoxemia is minimal in some studies and marked
in other studies.21,22 Dolbec et al.23 found no
regional differences in increased CBF values in
response to hypoxemia.
CBF increases in hypercapnia due to vasodilata-
tion in cerebral arterioles, capillaries and venous,
resulting in faster removal of CO2 from the
tissue.24,25 These changes in CBF happen through
central chemoreceptors. Some studies suggested
that central chemoreceptors play a major role26
whereas other studies suggested that these recep-
tors are less effective14 in the regulation.
Hypoxemia together with hypercapnia is a
frequent clinical entity. But the effect of this on
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variety of studies reported increase in CBF during
hypoxemia and hypercapnia and decrease during
hypocapnia.27–29 In case of hyperoxia CBF was
either decreased or not changed.30,31
The effects of acute and chronic changes in blood
gases on CBF varies. A decrease in cerebrovascular
response to PaCO2 changes in chronic hypercapnia
was reported.32 Levasseur et al.16 reported a
decrease in vasodilatation response of pial arteries
after prolonged hypercapnia. Scano et al.8 re-
ported that CO2 determines the decreased ventila-
tory response in COPD patients. Both respiratory
muscle impairment and insufficient chemoreceptor
response are responsible for this situation in
chronic hypercapnic COPD patients. Oca et al.
reported that effective ventilation was insufficient
in very severe COPD patients.9 Van de Ven et al.7
found that CBF during normocapnia and hypercap-
nia in COPD patients was lower than those in
healthy subjects. Either mechanical reasons or a
decrease in the effect of CO2 stimulation on
respiratory center in COPD were considered to be
the reason. As a result, ventilation was found to be
decreased in hypercapnia although it was expected
to increase.
Alterations in CBF due to PaCO2 changes were
investigated regionally; in hypercapnia marked
hyperperfusion was detected in pons, cerebellum,
thalamus and putamen and a gradual hypoperfusion
was detected in temporal, temporooccipital and
occipital cortices.12 Helou et al.33 studied sheep
fetus and Pelligrino et al.34 studied rats and they
found that vascular response was markedly in-
creased in pons, cerebellum, thalamus and puta-
men. In some studies, no differences were observed
between cerebral cortex and deep white substance
during hypercapnia, whereas in other studies
cerebrovascular response was found to be more
evident in cerebral cortex.12,35,36
Hypoxia is a significant cause of cell injury. It can
be due to decrease in vascular supply in arterial or
venous systems, insufficient oxygenization of blood
because of cardiac or pulmonary deficiency, or
decrease in oxygen transport capacity of blood
because of anemia. In the disturbances where the
oxygen demand of the brain is increased, such as
COPD and chronic anemia, some modifications in
the vasculature are made to supply this demand.
These modifications in the vascular system are
directed to increase the blood flow to the brain and
this increase is achieved by increasing blood flow
velocity and vascular lumen diameter, either alone
or together. In a study with anemic patients, the
increase in CBF was reported to be negatively
correlated with hemoglobin. In that study, particu-larly, VA lumen was increased in anemic patients.37
In a study with chronic hypercapnic COPD patients,
oxygen replacement treatment was shown to
decrease CBF velocity, detected with transcranial
Doppler ultrasound.5
Doppler ultrasound of extracranial carotid and VA
is a well-established method to assess cerebrovas-
cular circulation. It has been used for the evalua-
tion of effects of various diseases or conditions.
This technique measures tCBFV by applying it to
bilateral internal carotid and vertebral arteries,
which has been shown to be a precise and reliable
approach.10,11
To the best of our knowledge, this is the first
study that evaluates ICA and VA blood flow volumes
separately in patients with COPD by using Doppler
ultrasound. In the present study tCBFV, aCBFV,
pCBFV, left and right ICA flow volumes, bilateral ICA
and VA cross-sectional areas and left ICA Vps were
markedly increased in COPD patients. Ellingsen
et al.18 reported that ICA flow rates were directly
proportional with blood CO2 levels. Ito et al.
12
reported that the increase in CBF due to hyper-
capnia in healthy subjects was related with
vascular blood flow velocity. In our study, the flow
velocity values were higher in COPD patients,
particularly those with hypoxemia and hypercap-
nia, compared with control group. But only left ICA
Vps was statistically significant. Bilateral ICA and VA
cross-sectional areas were markedly increased, and
in our study, this was the main reason of increased
tCBFV in COPD patients.
Increased tCBFV due to blood gas alterations in
COPD patients in our study are in agreement with
the results of similar studies in healthy human
subjects or animals using PET,12 carotid artery
Doppler ultrasound,18 magnetic resonance ima-
ging,23 and transcranial Doppler ultrasound meth-
ods.38 Our results are in contrast with the results of
the study of Van de Ven et al.7 in COPD patients
with NIRS method.
There are other reasons than blood gas changes,
increasing and decreasing CBF in COPD patients.
Aging, arterial hypertension, polycythemia, amino-
phylline and systemic corticosteroids use decreased
CBF in COPD patients.7,10,39–41 But there was no
significant correlation between CBFV and age,
blood pressure, medication in our study.
Chronic hypercapnia, a reversible syndrome of
headache, papilledema and impaired consciousness
with tremor of the extremities has been described
in patients with chronic pulmonary insufficiency.42
The headaches are attributed to the increased
intracranial pressure. Increased CBF is elevated
intracranial pressure in normal population.43 Blood
gases changed in COPD patients can raise
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pressure may produce papilledema that can pro-
gress to blindness. Ventilatory support and discon-
tinuation of sedative drugs constitute effective
treatment. Vigorous hyperventilation must be
avoided as renewed obtunation, seizures and even
death may result, presumably from hyperventila-
tion-induced cerebral vasoconstriction.42
RI is thought to be correlated to vascular
resistance, and reported to be a good marker for
predicting the prognosis of perinatal asphyxia.44
Archer et al.45 found 100% sensitivity of a low RI
with increased diastolic flow in the anterior
cerebral artery and middle cerebral artery. In our
study there were no significant differences in RI and
PI values of ICA and VA between COPD patients and
control group.
As a conclusion, bilateral ICA and VA cross-
sectional areas and left ICA Vps are the basic
parameters causing high tCBFV, aCBFV and pCBFV
in COPD patients. Increased tCBFV in normocapnic
COPD patients, those similar to control group with
regard to blood gas values, suggests a possible
compensatory mechanism developed for covering
the increased oxygen demand. Hypoxia alone and
hypoxia with hypercapnia emphasizes the increase
in tCBFV. In our study, low number of cases was the
major limitation. Further studies of tCBFV mea-
surements using Doppler ultrasound comparing
enough COPD patients and control subjects with
adjusted blood gases need to be performed.References
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